• Nenhum resultado encontrado

Rev. bras. farmacogn. vol.25 número2

N/A
N/A
Protected

Academic year: 2018

Share "Rev. bras. farmacogn. vol.25 número2"

Copied!
3
0
0

Texto

(1)

RevistaBrasileiradeFarmacognosia25(2015)142–144

w w w. s b f g n o s i a . o r g . b r / r e v i s t a

Original

Article

Study

of

hypocholesterolemic

activity

of

Algerian

Pistacia

lentiscus

leaves

extracts

in

vivo

Mohammed

Cheurfa

,

Rachida

Allem

LaboratoryofNaturalBioresources,DepartmentofBiology,FacultyofScience,UniversityofHassibaBenBoualiChlef,Box151,02000Chlef,Algeria

a

r

t

i

c

l

e

i

n

f

o

Articlehistory:

Received15September2014 Accepted1February2015 Availableonline31March2015

Keywords: Aqueousextract Ethanolicextract

Hypocholesterolemicactivity Pistacialentiscusleaves

a

b

s

t

r

a

c

t

Plantsarealargesourceofnewbioactivemoleculeswiththerapeuticpotentials.However,onlyasmall amountofworldwideplantshavebeenphytochemicallyinvestigated.Theaqueousandethanolicextracts

ofPistacialentiscusL.,Anacardiaceae,leaveswereevaluatedforhypocholesterolemicactivityinvivo.In

thisstudy,hypercholesterolemiawasinducedinanimalsbyfeedingthemhighcholesterol(1%)food.The extractsofP.lentiscuswereorallyadministeredatadoseof200mg/kgbodyweightalongwithahigh cholesteroldietforthirtysuccessivedays.Lipidparameterssuchastotalcholesterol,triacylglyceride, lowdensitylipoprotein,verylowdensitylipoproteinandhighdensitylipoproteinweremeasuredin theplasma.Totalphenolandflavonoidcontentswerealsoevaluated.Flavonoidcontentwasfoundto bemorepresentintheethanolicextract(8.218±0.009mgofQE/g)comparedtotheaqueousextract (3.107±0.014mgofQE/g).TheadministrationofP.lentiscusextractsproducedasignificantdecreasein totalcholesterol,triacylglycerideandlowdensitylipoprotein-cholesterol(154.6±18.10,71.2±4.38and 99.36±18.77mg/dlrespectively)intheethanolicextract,whiletheaqueousextractshowedasignificant decreaseintotalcholesterolandtriacylglyceride(203.6±9.18and97.6±3.57mg/dlrespectively).The resultsoftheinvestigationdemonstratedthatP.lentiscusleafextracthashypocholesterolemicproperties andmightbeusedforthepreventionofhypercholesterolemiaassociateddisorders.

©2015SociedadeBrasileiradeFarmacognosia.PublishedbyElsevierEditoraLtda.Allrightsreserved.

Introduction

Increases in cholesterol levels (hypercholesterolemia) have becomea significanthealth concernin recentyears. Hypercho-lesterolemia is known tobe a risk factor for thedevelopment of cardiovasculardiseases includingatherosclerosis, myocardial infarctionandcerebralparalysis(Avcıetal.,2006).This dysfunc-tionalsoenhancesfreeradicalgenerationinvariousways(Prasad andKalra,1993),aswellastheformationofoxygenfreeradicals, suchassuperoxideanionradicalorperoxynitrite,whichplaya sig-nificantroleinthepathogenesisofmanyotherdiseasesincluding, cancerandinflammatorydisorders(Dasetal.,2000).

Curinghypercholesterolemiawithoutanysideeffectsremains achallengeformodernmedicine.Plant-derivedproductsare fre-quentlyconsideredtobelesstoxic,withfewornosideeffects,than theirsyntheticequivalents.Plantsplayamajorroleinthe introduc-tionofnewtherapeuticagents,andhavereceivedmuchattention as sources of biologically active substances. Mastic (Pistacia lentiscus)isonesuchexample.

∗ Correspondingauthor.

E-mail:[email protected](M.Cheurfa).

P.lentiscusisverycommonintheMediterraneanregion.In Alge-ria,masticisfoundinboththeTellregionandinforestedareas.The aerialportionhastraditionallybeenusedasbothastimulantand adiureticinthetreatmentofhypertension,coughs,sorethroats andstomachaches.P.lentiscusleavescontainbioactivemolecules suchasphenoliccompounds(proanthocyanidintanninsandgallic), flavonoidglycosidesandanthocyanins.

Theaimofthisstudyishencetostudythehypocholesterolemic activityinvivoof aqueousandethanolic extractsofAlgerian P. lentiscusleaves.

Materialsandmethods

Plantmaterial

PistacialentiscusL.,Anacardiaceae,leaveswerecollectedlocally fromtheChlefregionofAlgeriain2012.Voucherspecimenswere collectedundertheregistrationnumberFSDB12.189,atthe herbar-iumofDepartmentofBiology,FacultyofSciences,Universityof HassibaBenBouali-Chlef.TheywereidentifiedbyMs.MedjahedK, abotanistattheInstituteofAgronomy,UniversityofHassibaBen Bouali-Chlef.Afterdryinginashadowatroomtemperature,the plantmaterialswerefragmented.

http://dx.doi.org/10.1016/j.bjp.2015.02.011

(2)

M.Cheurfa,R.Allem/RevistaBrasileiradeFarmacognosia25(2015)142–144 143

Preparationofaqueousextract

Theaqueousextractwaspreparedbydecoction.Fragmented leaves(100g)wereimmergedinoneliterofwaterat100◦Cfor 15min.TheaqueousextractwasfilteredthroughWhatmanpaper N◦1.Thefiltratewasconcentratedinarotaryvacuumevaporator at55◦C.Theextractionyieldwas11.88%.

Preparationofethanolicextract

Theethanolicextractwaspreparedbyhomogenizing100gof fragmentedleavesin 900mlof ethanolsolution(50%)for three days,withfrequent agitation.Theethanolicextractwasfiltered throughWhatmanpaperN◦1.Thesolventwasremovedfromthe sampleusingarotaryvacuumevaporatorat48◦C(Peixotoetal.,

2011).Theextractionyieldwas15.88%.Alloftheabovedryextracts werestoredat4◦Cinsterileglassjarsand,sealedforuseinfurther studies.

Phytochemicalsscreeningoftheleavesextracts

Determinationoftotalflavonoidcontent

Thetotalflavonoidcontentintheextractswasdetermined spec-trophotometricallyusinganaluminumchloridemethodinvolving theformationofaflavonoid–aluminumcomplexat420nm(Zhou etal.,2005).Theconcentrationofthetotalflavonoidcontentwas calculatedbycomparison withtheabsorbanceof different con-centrationsof quercetin(QE), and theresult was expressedas milligramsofQEequivalentspergramofplantpowder.Samples werepreparedintriplicateforeachanalysis,andthemeanvalue ofabsorbancewasobtained.

Assayofhypocholesterolemicactivityinvivo

Animals

Twenty-five male Swiss albino mice weighing between 25 and 30g were used in the present study. They were housed in polypropylene cages with controlled levels of temperature (24±2◦C)andlight(a12hlight,12hdarkphotoperiod),andfed withstandardlaboratorypellets.Foodandwater weregivenad libitum.

Theprotocolemployedwasapprovedbythelaboratoryof tox-icologyandpharmacology(Antibioticalgroup–Medea,Algeria), followingtherecommendationsoftheEuropeanPharmacopoeia 8.0underreferencenumber215/2013.

Experimentaldesign

Hypercholesterolemiawasinducedinthemicevia administer-ingof foodcontaining highcholesterol (1%)for thirty days. All micehad freeaccesstofoodand water fortheduration ofthe experiment.Thetestgroupreceived200mg/kgbodyweightplant extractsat10ml/kgeverymorning,administeredorally.Themice weredividedintofivegroupsoffiveanimalseachasfollows:

Group1:Receivednormaldiet(controlgroup).

Group2:Fedwithahighcholesteroldietandreceived0.5mlof sterilewater,administeredorally.

Group3:Fedwithahighcholesteroldietandreceivedaqueous extractofP.lentiscus,200mg/kgbodyweightfor30days, admin-isteredorally.

Group4:Fedwithahighcholesteroldietandreceivedethanolic extractofP.lentiscus,200mg/kgbodyweightfor30days, admin-isteredorally.

Group5:Fedwithahighcholesteroldietandreceivedreference drugAtorvastatin,10mg/kgbodyweight(KheraandBhatia,2012) forthirtydays,administeredorally.

Attheendoftheexperiment,bloodsampleswerecollectedfrom themiceinallgroupsinvialswithoutanti-coagulant.Biochemical parametersmeasuredinthestudywereTC(totalcholesterol),TG (triacylglyceride),LDL(lowdensitylipoprotein),HDL(highdensity lipoprotein)andVLDL(verylowdensitylipoprotein),usingassay kits(BeckmanCoulter,Ref:467825,445850,969706,and650207 –USA.).

Statisticalanalysis

The experimental results were expressed as mean SEM (standarderroroftheman).DatawereassessedbyANOVA.Tukey’s testwasthenappliedusingXLStatPro7.5software.Apvalueof <0.05wasconsideredtobestatisticallysignificant.

Results

Flavonoidcontent

Flavonoid levelsin the aqueousand ethanolicextracts of P. lentiscusleaveswere3.107±0.014and8.218±0.009mgofQE/g respectively.Ebrahimzadehetal.(2008)testedthegumofP. lentis-cus.Theyfoundtheflavonoidlevelstobe30.52±1.10mgofQE/g. Aflavonoidcontentof38.7±0.02mgofQE/gwasfoundbyCherbal etal.(2012)forthemethanolextractofP.lentiscusleaves.

Hypocholesterolemicactivityinvivo

Table1showsthevaluesofserumlipidprofileinthenormal, hypercholesterolemic,controlandextracttreatedgroups.

Cholesterolandtriacylglycerideareimportantbuildingblocks in the structure of biological membranes. They are also used in thebiosynthesisof steroidhormones.However,high choles-terolconcentrationinthebloodincreasestheriskofdeveloping atherosclerosisandrelatedcardiovasculardiseases.

In the present study, mice fed with a high cholesterol diet had higher (p<0.05) levels of total cholesterol in the serum (253±31.60mg/dl) than mice fed with a normal diet (116±0.89mg/dl).

The treatment of group 3 with aqueous extract of P. lentiscus at 200mg/kg body weight, significantly decreased TC (203.6±9.18mg/dl)andTG(97.6±3.57mg/dl)comparedtothe hypercholesterolemiccontrol(group 2).However,there wasno significantdecreaseinLDL-cholesterol.

In the cholesterol-fed mice (group 4), the treatment with 200mg/kgbodyweightofP.lentiscusethanolicextractalso signif-icantlydecreasedTC(154.6±18.10mg/dl),TG(71.2±4.38mg/dl) andLDL-cholesterol(99.36±18.77mg/dl).

TC,TGandLDL-cholesterolalsoshowedasignificantdecrease ascomparedtothehighcholesterol-fedmicereceiving10mg/kg bodyweightdosesofatorvastatin(group5).

P.lentiscus leafextractsshowedanon-significantincreaseof HDL-cholesterollevelincomparisontothehypercholesterolemic control(group2).

Discussion

(3)

144 M.Cheurfa,R.Allem/RevistaBrasileiradeFarmacognosia25(2015)142–144

Table1

EffectofaqueousandethanolicextractofP.lentiscusonserumlipidprofileofmicefedwithhighcholesteroldietafter30days.

Groups Dose(mg/kg) TC(mg/dl) TG(mg/dl) HDL-c(mg/dl) LDL-c(mg/dl) VLDL-c(mg/dl)

Controlgroup 116±0.89 146.4±10.89 48.2±6.40 38.52±8.13 29.28±2.17 Hypercholesterolaemicgroup 253±31.60# 200±12.32# 31.6±1.74# 160±31.60# 40±2.46#

AqP.lentiscus 200 203.6±9.18* 97.6±3.57*** 38.2±1.48 145.88±9.76 19.52±0.71**

EtP.lentiscus 200 154.6±18.10*** 71.2±4.38*** 41±1.87 99.36±18.77* 14.24±0.87**

Atorvastatin 10 130.6±8.14*** 121.8

±42.65*** 62.8

±3.49*** 43.44

±9.35*** 24.36

±8.53

Aq:aqueousextract. Et:ethanolicextract.

* p<0.05significantfromhypercholesterolaemiccontrol.

** p<0.01significantfromhypercholesterolaemiccontrol.

***p<0.001significantfromhypercholesterolaemiccontrol.

#p<0.05significantfromcontrolanimals.

(suchasgeographicandclimaticfactors),geneticfactors,degreesof maturationoftheplant,andstoragetimeallhaveastronginfluence onthecontentofphenoliccompounds(Fallehetal.,2008).

Highlevelsofcholesterolinthediethavebeenshownto ele-vatetotalcholesterol,andmayincreasetheriskofcardiovascular complications.

Regarding thecholesterol-lowering effect of P. lentiscus leaf extractsinmicefedwithahigh-cholesteroldiet,theP.lentiscus

extractsshowedhypocholesterolemicproperties.Thismaybedue toeithertheindividualorthesynergisticactionofthephenolic components. A possible mechanism here may bethe hydroly-siscontrolofcertainlipoproteinsandtheirselectiveuptakeand metabolismbydifferenttissues.

Flavonoidsmayenhancethelecithinacyltransferase(LCAT)by increasingtheiractivity,whichregulatesbloodlipids(Yooetal., 2008).LCATplaysakeyroleintheincorporationoffreecholesterol intoHDL(thismayincreaseHDL)anditstransferbacktoVLDLand LDL,whicharelaterreturnedinlivercells(DobiásováandFrohlich, 1999).

Flavonoidsmight representanother beneficial groupof nat-urallyoccurringhypolipidemiccompounds (Cookand Samman, 1996), and they appear tohave intensivebiological properties thatpromotehumanhealthandhelpreducetheriskofdisease. Flavonoidsactasantioxidants,protectLDLcholesterolfrom oxida-tion,inhibitplateletaggregation,andactasanti-inflammatoryand anti-tumoragents(CookandSamman,1996;Manachetal.,1996). Inadditiontodirectoxidantscavenging,flavonoidsmayinhibit theenzymesinvolved ingeneratingpro-oxidant molecules.For example,flavonoidshavebeenshowntoinhibitthegenerationor releaseoffreeradicalsderivedfromlipoxygenase(LOX).Ithasbeen suggestedthatLOXisinvolvedintheearlyeventsof atherosclero-sisbyinducingplasmaLDLoxidationinthesubendothelialspace ofthearterialwall(Huangetal.,1997).

Inconclusion,thepresentstudyclearly demonstratesthatP. lentiscusleafextractisrichinphenoliccompounds.Furthermore, intermsofhypercholesterolemicactivity,P.lentiscusextracts sig-nificantlydecreaseTClevelsinplasma.Futurestudiesareproposed inordertoconfirmtheseresults.

Authors’contributions

MCdidtheanalysis,interpretationandacquisitionofthedata anddraftedthepaper.RAdesignedthestudy,supervisedthe labo-ratoryworkandcontributedtocriticalreadingofthemanuscript.

Boththeauthorshavereadthefinalmanuscriptandapprovedfor submission.

Conflictsofinterest

Theauthorsdeclarenoconflictsofinterest.

Acknowledgements

TheauthorswouldliketothankMr.BenonaM,BoukhelkhalK andMs.NegabI,fromAntibioticalgroup,Medea,Algeria.

References

Avcı,G.,Kupeli,E.,Eryavuz,A.,Yesilada,E.,Kucukkurt,I.,2006. Antihypercholes-terolaemicandantioxidantactivityassessmentofsomeplantsusedasremedy inTurkishfolkmedicine.J.Ethnopharmacol.107,418–423.

Cherbal,A.,Kebeiche,M.,Madani,K.,El-Adawi,H.,2012.Extractionandvalorization ofphenoliccompoundsofleavesofAlgerianPistacialentiscus.AsianJ.PlantSci. 11,131–136.

Cook,N.C.,Samman,S.,1996.Flavonoids—chemistry,metabolism,cardioprotective effects,anddietarysources.J.Nutr.Biochem.7,66–76.

Das,S.,Vasisht,S.,Das,S.N.,Srivastava,L.M.,2000.Correlationbetweentotal antiox-idantstatus andlipidperoxidationinhypercholesterolaemia.Curr.Sci.78, 486–487.

Dobiásová,M.,Frohlich,J.,1999.Advancesinunderstandingoftheroleoflecithin cholesterolacyltransferase(LCAT)incholesteroltransport.Clin.Chim.Acta286, 257–271.

Ebrahimzadeh,M.A.,Pourmorad,F.,Bekhradnia,A.R.,2008.Ironchelating activ-ity,phenolandflavonoidcontentofsomemedicinalplantsfromIran.Afr.J. Biotechnol.7,3188–3192.

Falleh,H.,Ksouri,R.,Chaieb,K.,Karry-Bouraoui,N.,Trabelsi,N.,Boulaaba,M.,Abdelly, C.,2008.PhenoliccompositionofCynaracardunculusL.organs,andtheir bio-logicalactivities.C.R.Biol.331,372–379.

Huang,Z.,Fasco,M.J.,Kaminsky,L.S.,1997.Inhibitionofestronesulfataseinhuman livermicrosomesbyquercetinandotherflavonoids.J.SteroidBiochem.Mol. Biol.63,9–15.

Khera,N.,Bhatia,A.,2012.Antihyperlipedemic activityofWoodfordiafruticosa extractinhighcholesteroldietfedmice.Int.J.Pharm.Phytopharmacol.Res. 2,211–215.

Manach,C.,Regerat,F.,Texier,O.,1996.Bioavailability,metabolismand physiolog-icalimpactof4-oxo-flavonoids.Nutr.Res.16,517–544.

Peixoto,J.R.O.,Silva,G.C.,Costa,R.A.,Fontenelle,J.L.S.,Vieira,G.H.F.,Filho,A.A.F., Fer-nandesVieira,R.H.S.,2011.Invitroantibacterialeffectofaqueousandethanolic Moringaleafextracts.AsianPac.J.Trop.Med.4,201–204.

Prasad, K., Kalra, J., 1993. Oxygen free radicals and hypercholesterolaemic atherosclerosis:effectofVitaminE.Am.HeartJ.125,958–973.

Yoo,C.L.,Su,P.Q.,Zhou,X.X.,2008.StudyoneffectandmechanismofScutellaria baicalensisstem-leaftotalflavonoidinregulatinglipidmetabolism.Zhongguo ZhongYaoZAZhi33,1046–1056.

Referências

Documentos relacionados

Group one was given saline orally and served as the control; group two received 4 mg/kg of diazepam (ip), group three received 50 mg/kg BM orally, group four received 50 mg/kg

2008; Rosidah et al ., 2009; Hor et al ., 2011). Six animals received distilled water and were regarded as the control group. All treatments were administered at 5 mL/kg

“In group 5 (100mg/kg/day of Ginkgo biloba and, after 90 minutes, methamidophos 3,0 mg/Kg/day during 7 days), all the outer hair cells kept its normal shape and arrangement at the

“In group 5 (100mg/kg/day of Ginkgo biloba and, after 90 minutes, methamidophos 3,0 mg/Kg/day during 7 days), all the outer hair cells kept its normal shape and arrangement at the

Three days after STZ (40 mg/kg body weight) administration, the STZ group had their body weight, plasma glucose (339-387 mg/dl), urinary glucose and food intake meas- ured and

No deaths were induced and no other signs of toxicity were apparent in male rats treated orally with ß-myrcene (100, 300 and 500 mg/kg body weight) for 91 days prior to mating

Since the dose of bixin administered to the former group (70 mg/kg body weight) was approxi- mately three times lower than that given to the latter group (250 mg/kg body

This study demonstrates that policosanol (25 and 200 mg/kg) administered orally to rabbits fed a cholesterol-rich diet was effec- tive in preventing the development of ath-